Literature DB >> 32915973

Stable HLA antibodies following sustained CD19+ cell depletion implicate a long-lived plasma cell source.

Zheng Zhang1,2,3, Stephen J Schuster4, Simon F Lacey2,3, Michael C Milone2,3, Dimitri Monos2, Vijay G Bhoj2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32915973      PMCID： PMC7509856          DOI： 10.1182/bloodadvances.2020002435

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  25 in total

1.  Pharmacodynamics of rituximab in kidney allotransplantation.

Authors:  H Genberg; A Hansson; A Wernerson; L Wennberg; G Tydén
Journal:  Am J Transplant       Date:  2006-08-21       Impact factor: 8.086

2.  Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.

Authors:  Vijay G Bhoj; Dimitrios Arhontoulis; Gerald Wertheim; James Capobianchi; Colleen A Callahan; Christoph T Ellebrecht; Amrom E Obstfeld; Simon F Lacey; Jan J Melenhorst; Farzana Nazimuddin; Wei-Ting Hwang; Shannon L Maude; Mariusz A Wasik; Adam Bagg; Stephen Schuster; Michael D Feldman; David L Porter; Stephen A Grupp; Carl H June; Michael C Milone
Journal:  Blood       Date:  2016-05-10       Impact factor: 22.113

3.  Lifetime of plasma cells in the bone marrow.

Authors:  R A Manz; A Thiel; A Radbruch
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

4.  Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

Authors:  Stephen J Schuster; Jakub Svoboda; Elise A Chong; Sunita D Nasta; Anthony R Mato; Özlem Anak; Jennifer L Brogdon; Iulian Pruteanu-Malinici; Vijay Bhoj; Daniel Landsburg; Mariusz Wasik; Bruce L Levine; Simon F Lacey; Jan J Melenhorst; David L Porter; Carl H June
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

5.  Limitations of rituximab/IVIg desensitization protocol in kidney transplantation; is this better than a tincture of time?

Authors:  Tomasz Kozlowski; Kenneth Andreoni
Journal:  Ann Transplant       Date:  2011 Apr-Jun       Impact factor: 1.530

6.  Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.

Authors:  Sylvain Audia; Maxime Samson; Julien Guy; Nona Janikashvili; Jennifer Fraszczak; Malika Trad; Marion Ciudad; Vanessa Leguy; Sabine Berthier; Tony Petrella; Serge Aho-Glélé; Laurent Martin; Marc Maynadié; Bernard Lorcerie; Patrick Rat; Nicolas Cheynel; Emmanuel Katsanis; Nicolas Larmonier; Bernard Bonnotte
Journal:  Blood       Date:  2011-08-29       Impact factor: 22.113

7.  Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Authors:  Jessica L Halliley; Christopher M Tipton; Jane Liesveld; Alexander F Rosenberg; Jaime Darce; Ivan V Gregoretti; Lana Popova; Denise Kaminiski; Christopher F Fucile; Igor Albizua; Shuya Kyu; Kuang-Yueh Chiang; Kyle T Bradley; Richard Burack; Mark Slifka; Erika Hammarlund; Hao Wu; Liping Zhao; Edward E Walsh; Ann R Falsey; Troy D Randall; Wan Cheung Cheung; Iñaki Sanz; F Eun-Hyung Lee
Journal:  Immunity       Date:  2015-07-14       Impact factor: 31.745

8.  Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.

Authors:  Olivier Aubert; Alexandre Loupy; Luis Hidalgo; Jean-Paul Duong van Huyen; Sarah Higgins; Denis Viglietti; Xavier Jouven; Denis Glotz; Christophe Legendre; Carmen Lefaucheur; Philip F Halloran
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

9.  Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers.

Authors:  Elizabeth F Wallin; Elaine C Jolly; Ondřej Suchánek; J Andrew Bradley; Marion Espéli; David R W Jayne; Michelle A Linterman; Kenneth G C Smith
Journal:  Blood       Date:  2014-09-15       Impact factor: 22.113

Review 10.  The Pharmacology of T Cell Therapies.

Authors:  Michael C Milone; Vijay G Bhoj
Journal:  Mol Ther Methods Clin Dev       Date:  2018-01-31       Impact factor: 6.698
View more
  2 in total

1.  Long-term Persistence of Allosensitization After Islet Allograft Failure.

Authors:  Paola Rios; David Baidal; Joana Lemos; Stephanie S Camhi; Marco Infante; Nathalia Padilla; Ana M Alvarez Gil; Virginia Fuenmayor; Jonathan Ambut; Fatima A Qasmi; Alejandro M Mantero; Shari Messinger Cayetano; Phillip Ruiz; Camillo Ricordi; Rodolfo Alejandro
Journal:  Transplantation       Date:  2021-11-01       Impact factor: 5.385

Review 2.  Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments.

Authors:  Massimiliano Bertacchi; Paloma Parvex; Jean Villard
Journal:  Clin Transplant       Date:  2022-02-16       Impact factor: 3.456
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.